Related Experiment Video
Updated: Nov 16, 2025
10:44
Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
10.1K
The CYP2R1 Enzyme: Structure, Function, Enzymatic Properties and Genetic Polymorphism
Amelia Nathania Dong, Boon Hooi Tan, Yan Pan
1Monash University Malaysia.
Summary
Cytochrome P450 2R1 (CYP2R1) is crucial for vitamin D metabolism. Genetic variations in CYP2R1 influence vitamin D levels and disease risk, requiring further research.
Area of Science:
- Biochemistry
- Genetics
- Molecular Biology
Background:
- Cytochrome P450 2R1 (CYP2R1) plays a key role in vitamin D metabolism.
- Understanding CYP2R1's gene organization, protein structure, and function is essential.
Purpose of the Study:
- To review the current understanding of CYP2R1's structure, function, and genetic variations.
- To highlight the association of CYP2R1 with vitamin D levels and diseases.
Main Methods:
- Structural analysis of CYP2R1 protein.
- Review of genetic polymorphism studies, including single nucleotide polymorphisms (SNPs).
- Examination of CYP2R1's role in vitamin D 25-hydroxylation.
Main Results:
- CYP2R1 has a unique gene structure with five exons.
- Its crystal structure reveals a typical CYP fold with a closed conformation.
- CYP2R1 25-hydroxylates vitamin D in the liver, impacting circulating levels.
- Specific SNPs, like rs10741657, are linked to rickets, ovarian cancer, and multiple sclerosis.
Conclusions:
- CYP2R1 is a critical enzyme in vitamin D metabolism.
- Genetic variations in CYP2R1 significantly impact vitamin D levels and disease susceptibility.
- Further research is needed to elucidate the functional consequences of other CYP2R1 SNPs and their links to complex traits.
Related Concept Videos
01:19Allosteric Proteins-ATCase
6.2K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.2K
02:34Enzymes
88.3K
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
88.3K
01:30Enzyme Inhibition
88.6K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
88.6K
01:19Factors Affecting Drug Biotransformation: Biological
380
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
380
01:17Drug Metabolism: Phase I Reactions
4.2K
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
4.2K
01:21Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs
579
A drug's physicochemical properties fundamentally influence its metabolism. For instance, a drug's molecular size and shape critically determine its interaction with enzymes and transporters — larger drugs may face difficulty reaching enzyme active sites, altering their metabolic pathways. The pKa of a drug, which establishes its ionization state, can impact its solubility and absorption, thereby influencing metabolism.
The drug's acidity or basicity is essential in...
The drug's acidity or basicity is essential in...
579